Transfer Factor Max is supported by three clinical studies covering rapid immune activation, stem cell mobilization, and neutrophil function — plus thousands of published studies on its individual ingredients.
📘 New: our honest breakdown of the clinical studies explains what each one actually measured, which are peer-reviewed and independent, and the difference between "clinically studied" and "clinically proven." The Complete 2026 Guide covers the broader product context.
A feasibility trial published in 2024 documented immune cell activation within two hours of taking the Tri-Factor Blend at 600 mg per serving. This is the basis for the "activates the immune system in under 2 hours" claim on the Transfer Factor Max label.
Demonstrated that consumption of the Transfer Factor Max formula increased the mobility of immune stem cells — the cells responsible for replenishing the body's population of white blood cells. This is the foundation of Max's "targeted renewal" capability.
Evaluated the activity and numbers of neutrophils in subjects taking Transfer Factor Max. Combined with the supporting research, the formula activates over 90% of the body's key immune cell types.